XML 34 R23.htm IDEA: XBRL DOCUMENT v3.7.0.1
OTHER FINANCIAL INFORMATION Condensed Cash Flow Statement (Tables)
3 Months Ended
Mar. 31, 2017
Condensed Cash Flow Statements, Captions [Line Items]  
Condensed Cash Flow Statement [Table Text Block]
 
Condensed Consolidating Statement of Cash Flows
 
Three Months Ended
 
March 31, 2017
 
 
 
 
 
 
 
 
 
 
(In thousands of dollars)
WESCO
International,
Inc.
 
WESCO
Distribution,
Inc.
 
Non-Guarantor
Subsidiaries
 
Consolidating
and Eliminating
Entries
 
Consolidated
Net cash provided by operating activities
$
4,316

 
$
24,580

 
$
18,744

 
$

 
$
47,640

Investing activities:

 

 

 

 

Capital expenditures

 
(1,487
)
 
(3,003
)
 

 
(4,490
)
Dividends received from subsidiaries

 
16,979

 

 
(16,979
)
 

Other

 
(14,834
)
 
4,398

 
10,469

 
33

Net cash provided by (used in) investing activities

 
658

 
1,395

 
(6,510
)
 
(4,457
)
Financing activities:
 
 
 
 
 
 
 
 
 
Borrowings
2,220

 
167,299

 
164,118

 
(14,834
)
 
318,803

Repayments

 
(190,665
)
 
(180,265
)
 
4,365

 
(366,565
)
Repurchases of common stock
(6,536
)
 

 

 

 
(6,536
)
Increase in bank overdrafts

 
4,062

 

 

 
4,062

Dividends paid by subsidiaries

 

 
(16,979
)
 
16,979

 

Other

 
(452
)
 

 

 
(452
)
Net cash used in financing activities
(4,316
)
 
(19,756
)
 
(33,126
)
 
6,510

 
(50,688
)
Effect of exchange rate changes on cash and cash equivalents

 

 
374

 

 
374

Net change in cash and cash equivalents

 
5,482

 
(12,613
)
 

 
(7,131
)
Cash and cash equivalents at the beginning of period

 
41,552

 
68,579

 

 
110,131

Cash and cash equivalents at the end of period
$

 
$
47,034

 
$
55,966

 
$

 
$
103,000

 
Condensed Consolidating Statement of Cash Flows
 
Three Months Ended
 
March 31, 2016
 
 
 
 
 
 
 
 
 
 
(In thousands of dollars)
WESCO
International,
Inc.
 
WESCO
Distribution,
Inc.
 
Non-Guarantor
Subsidiaries
 
Consolidating
and Eliminating
Entries
 
Consolidated
Net cash (used in) provided by operating activities
$
(3,138
)
 
$
62,678

 
$
19,028

 
$

 
$
78,568

Investing activities:

 

 

 

 

Capital expenditures

 
(3,084
)
 
(524
)
 

 
(3,608
)
Acquisition payments, net of cash acquired

 
(50,348
)
 

 

 
(50,348
)
Dividends received from subsidiaries

 
15,310

 

 
(15,310
)
 

Other

 
(14,548
)
 
(3,783
)
 
10,183

 
(8,148
)
Net cash used in investing activities

 
(52,670
)
 
(4,307
)
 
(5,127
)
 
(62,104
)
Financing activities:
 
 
 
 
 
 
 
 
 
Borrowings
3,603

 
284,972

 
69,969

 
(14,548
)
 
343,996

Repayments

 
(309,337
)
 
(84,893
)
 
4,365

 
(389,865
)
Increase in bank overdrafts

 
11,972

 

 

 
11,972

Dividends paid by subsidiaries

 

 
(15,310
)
 
15,310

 

Other
(465
)
 
(412
)
 

 

 
(877
)
Net cash provided by (used in) financing activities
3,138

 
(12,805
)
 
(30,234
)
 
5,127

 
(34,774
)
Effect of exchange rate changes on cash and cash equivalents

 

 
5,865

 

 
5,865

Net change in cash and cash equivalents

 
(2,797
)
 
(9,648
)
 

 
(12,445
)
Cash and cash equivalents at the beginning of period

 
38,963

 
121,316

 

 
160,279

Cash and cash equivalents at the end of period
$

 
$
36,166

 
$
111,668

 
$

 
$
147,834